Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Xintao Shuai
Reduction and pH Dual-Sensitive Nanovesicles Co-Delivering Doxorubicin and Gefitinib for Effective Tumor Therapy
RSC Advances
Chemistry
Chemical Engineering
Related publications
Lung Cancer Combination Therapy: Doxorubicin and Β-Elemene Co-Loaded, pH-sensitive Nanostructured Lipid Carriers
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Surface Modification of Doxorubicin-Loaded Nanoparticles Based on Polydopamine With pH-sensitive Property for Tumor Targeting Therapy
Drug Delivery
Medicine
Pharmaceutical Science
Theranostic pH-sensitive Nanoparticles for Highly Efficient Targeted Delivery of Doxorubicin for Breast Tumor Treatment
International Journal of Nanomedicine
Organic Chemistry
Biophysics
Biomaterials
Pharmaceutical Science
Medicine
Bioengineering
Drug Discovery
Nanoscience
Nanotechnology
Expansile Crosslinked Polymersomes for pH Sensitive Delivery of Doxorubicin
Biomaterials Science
Materials Science
Biomedical Engineering
Tumor Targeted Nanostructured Lipid Carrier Co-Delivering Paclitaxel and Indocyanine Green for Laser Triggered Synergetic Therapy of Cancer
RSC Advances
Chemistry
Chemical Engineering
Ly6C Hi Monocytes Delivering pH‐Sensitive Micelle Loading Paclitaxel Improve Targeting Therapy of Metastatic Breast Cancer
Advanced Functional Materials
Materials Science
Condensed Matter Physics
Electrochemistry
Nanoscience
Optical
Biomaterials
Magnetic Materials
Nanotechnology
Chemistry
Electronic
A Cost-Effective pH-sensitive Release System for Water Source pH Detection
Chemical Communications
Surfaces
Alloys
Materials Chemistry
Coatings
Metals
Optical
Magnetic Materials
Films
Catalysis
Chemistry
Electronic
Composites
Ceramics
Porous Au@Pt Nanoparticles: Therapeutic Platform for Tumor Chemo-Photothermal Co-Therapy and Alleviating Doxorubicin-Induced Oxidative Damage
Novel Polymer Micelle Mediated Co-Delivery of Doxorubicin and P-Glycoprotein siRNA for Reversal of Multidrug Resistance and Synergistic Tumor Therapy
Scientific Reports
Multidisciplinary